You might find that a drug is covered for one condition but not the other
This can help maintain consistent pain relief and seizure control
To confirm you got the full dose, look for the gray plunger at the end of the pen
Semaglutide is administered as a once-weekly subcutaneous (under the skin) self-injection, typically in the abdomen, thigh, or upper arm using a pre-filled auto-injector pen
If you suspect you are experiencing side effects from Ozempic, you can report these via the MHRA Yellow Card Scheme at yellowcard
Research shows that 10-15% of patients don't respond adequately to semaglutide, but for most people experiencing plateaus, the issue is a diminished response rather than a true non-response, making strategic adjustments more effective than abandoning treatment entirely